$UTI
Universal Technical Institute Inc Stock $uti

$uti Overview Financials Valuation SEC Filings Company Website

2021 Q3 Form 10-K Financial Statement

#000126165421000073 Filed on December 02, 2021

Income Statement

Concept	2021 Q3	2021	2020 Q3
Revenue	$97.48M	$335.1M	$76.33M
YoY Change	27.71%	11.41%	-12.93%
Cost Of Revenue	$22.20M	$77.58M	$17.10M
YoY Change	29.81%	8.51%	-19.34%
Gross Profit	$75.28M	$257.5M	$59.20M
YoY Change	27.17%	12.3%	-10.98%
Gross Profit Margin	77.23%	76.85%	77.56%
Selling, General & Admin	$62.27M	$153.3M	$52.90M
YoY Change	17.72%	3.11%	-12.85%
% of Gross Profit	82.72%	59.54%	89.36%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$3.557M	$14.03M	$2.980M
YoY Change	19.36%	18.87%	-8.87%
% of Gross Profit	4.72%	5.45%	5.03%
Operating Expenses	$62.50M	$320.1M	$53.10M
YoY Change	17.71%	5.09%	-12.95%
Operating Profit	$12.78M	$14.95M	$6.153M
YoY Change	107.72%	-486.13%	13.15%
Interest Expense	-$222.0K	$365.0K	$200.0K
YoY Change	-211.0%	3550.0%	-150.0%
% of Operating Profit	-1.74%	2.44%	3.25%
Other Income/Expense, Net	$10.00K	$236.0K	$100.0K
YoY Change	-90.0%	-81.52%	-66.67%
Pretax Income	$12.57M	$15.18M	$6.500M
YoY Change	93.37%	-685.31%	20.37%
Income Tax	$524.0K	$602.0K	$100.0K
% Of Pretax Income	4.17%	3.96%	1.54%
Net Earnings	$12.05M	$14.58M	$6.450M
YoY Change	86.74%	82.08%	17.77%
Net Earnings / Revenue	12.36%	4.35%	8.45%
Basic Earnings Per Share		$0.17	$0.10
Diluted Earnings Per Share	$351.6K	$0.17	$0.09
COMMON SHARES
Basic Shares Outstanding	32.82M shares	32.77M shares	32.61M shares
Diluted Shares Outstanding		33.12M shares

Balance Sheet

Concept	2021 Q3	2021	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$133.7M	$133.7M	$114.9M
YoY Change	16.38%	16.38%	75.69%
Cash & Equivalents	$133.7M	$133.7M	$76.80M
Short-Term Investments	$0.00	$0.00	$38.10M
Other Short-Term Assets	$8.068M	$26.98M	$6.489M
YoY Change	24.33%	9.24%	-11.49%
Inventory
Prepaid Expenses	$6.658M		$6.121M
Receivables	$17.15M	$13.48M	$35.41M
Other Receivables	$3.673M	$9.211M	$6.494M
Total Short-Term Assets	$183.4M	$183.4M	$180.2M
YoY Change	1.78%	1.77%	52.56%
LONG-TERM ASSETS
Property, Plant & Equipment	$281.1M	$281.1M	$217.4M
YoY Change	29.31%	29.31%	108.79%
Goodwill	$8.222M		$8.200M
YoY Change	0.27%		0.0%
Intangibles	$124.0K
YoY Change
Long-Term Investments	$4.627M	$4.627M	$4.494M
YoY Change	2.96%	2.82%	3.6%
Other Assets	$9.120M	$4.617M	$8.565M
YoY Change	6.48%	12.61%	-16.21%
Total Long-Term Assets	$329.2M	$329.2M	$261.8M
YoY Change	25.74%	25.74%	71.76%
TOTAL ASSETS
Total Short-Term Assets	$183.4M	$183.4M	$180.2M
Total Long-Term Assets	$329.2M	$329.2M	$261.8M
Total Assets	$512.6M	$512.6M	$442.0M
YoY Change	15.97%	15.97%	63.38%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$13.70M	$13.70M	$12.47M
YoY Change	9.87%	9.62%	24.3%
Accrued Expenses	$11.19M	$58.06M	$11.37M
YoY Change	-1.57%	-12.29%	-16.51%
Deferred Revenue	$57.65M		$40.69M
YoY Change	41.66%		-5.11%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$876.0K	$876.0K	$129.0K
YoY Change	579.07%	776.0%	-91.94%
Total Short-Term Liabilities	$132.7M	$132.7M	$121.6M
YoY Change	9.11%	9.14%	25.6%
LONG-TERM LIABILITIES
Long-Term Debt	$29.85M	$29.85M	$131.0K
YoY Change	22686.26%	29750.0%	-99.67%
Other Long-Term Liabilities	$7.570M	$160.8M	$8.925M
YoY Change	-15.18%	12.45%	-6.82%
Total Long-Term Liabilities	$37.42M	$190.6M	$9.056M
YoY Change	313.21%	33.23%	-5.45%
TOTAL LIABILITIES
Total Short-Term Liabilities	$132.7M	$132.7M	$121.6M
Total Long-Term Liabilities	$37.42M	$190.6M	$9.056M
Total Liabilities	$324.0M	$324.0M	$265.5M
YoY Change	22.07%	22.05%	69.91%
SHAREHOLDERS EQUITY
Retained Earnings	-$22.00M		-$32.97M
YoY Change	-33.29%		-26.19%
Common Stock	$142.3M		$141.0M
YoY Change	0.93%		-24.8%
Preferred Stock	$68.85M		$68.85M
YoY Change	0.0%		0.0%
Treasury Stock (at cost)	$365.0K		$365.0K
YoY Change	0.0%		-99.63%
Treasury Stock Shares	82.00K shares		82.00K shares
Shareholders Equity	$188.5M	$188.5M	$176.5M
YoY Change
Total Liabilities & Shareholders Equity	$512.6M	$512.6M	$442.0M
YoY Change	15.97%	15.97%	63.38%

Cashflow Statement

Concept	2021 Q3	2021	2020 Q3
OPERATING ACTIVITIES
Net Income	$12.05M	$14.58M	$6.450M
YoY Change	86.74%	82.08%	17.77%
Depreciation, Depletion And Amortization	$3.557M	$14.03M	$2.980M
YoY Change	19.36%	18.87%	-8.87%
Cash From Operating Activities	$40.40M	$55.19M	$21.15M
YoY Change	91.03%	400.23%	-26.74%
INVESTING ACTIVITIES
Capital Expenditures	-$7.341M	$61.59M	-$2.070M
YoY Change	254.64%	564.93%	80.0%
Acquisitions		$0.00
YoY Change
Other Investing Activities	$1.002M	$38.64M	-$6.500M
YoY Change	-115.42%	-205.85%	-7322.22%
Cash From Investing Activities	-$6.339M	-$22.95M	-$8.570M
YoY Change	-26.03%	-49.84%	708.49%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-2.866M	$24.82M	-2.820M
YoY Change	1.63%	-42.39%	-18.97%
NET CHANGE
Cash From Operating Activities	40.40M	$55.19M	21.15M
Cash From Investing Activities	-6.339M	-$22.95M	-8.570M
Cash From Financing Activities	-2.866M	$24.82M	-2.820M
Net Change In Cash	31.20M	$57.06M	9.760M
YoY Change	219.64%	582.19%	-59.88%
FREE CASH FLOW
Cash From Operating Activities	$40.40M	$55.19M	$21.15M
Capital Expenditures	-$7.341M	$61.59M	-$2.070M
Free Cash Flow	$47.74M	-$6.401M	$23.22M
YoY Change	105.61%	-461.64%	-22.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021	dei	Entity Central Index Key EntityCentralIndexKey	0001261654
CY2021	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2021
CY2021	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2021	dei	Amendment Flag AmendmentFlag	false
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2020Q3	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2021Q3	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesNoncurrent
CY2021	dei	Document Type DocumentType	10-K
CY2021	dei	Document Annual Report DocumentAnnualReport	true
CY2021	dei	Document Transition Report DocumentTransitionReport	false
CY2021	dei	Document Period End Date DocumentPeriodEndDate	2021-09-30
CY2021	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2021	dei	Entity Registrant Name EntityRegistrantName	UNIVERSAL TECHNICAL INSTITUTE, INC.
CY2021	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--09-30
CY2021	dei	Entity File Number EntityFileNumber	1-31923
CY2021	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2021	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	86-0226984
CY2021	dei	Entity Address Address Line1 EntityAddressAddressLine1	4225 East Windrose Drive
CY2021	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 200
CY2021	dei	Entity Address City Or Town EntityAddressCityOrTown	Phoenix
CY2021	dei	Entity Address State Or Province EntityAddressStateOrProvince	AZ
CY2021	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	85032
CY2021	dei	City Area Code CityAreaCode	623
CY2021	dei	Local Phone Number LocalPhoneNumber	445-9500
CY2021	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value
CY2021	dei	Trading Symbol TradingSymbol	UTI
CY2021	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2021	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2021	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2021	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2021	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2021	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2021	dei	Entity Small Business EntitySmallBusiness	false
CY2021	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2021	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	32832555	shares
CY2021Q1	dei	Entity Public Float EntityPublicFloat	186000000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133721000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76803000	USD
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	12256000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	12116000	USD
CY2021Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	0	USD
CY2020Q3	us-gaap	Held To Maturity Securities Current HeldToMaturitySecuritiesCurrent	38055000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17151000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35411000	USD
CY2021Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	5538000	USD
CY2020Q3	us-gaap	Notes And Loans Receivable Gross Current NotesAndLoansReceivableGrossCurrent	5184000	USD
CY2021Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6658000	USD
CY2020Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	6121000	USD
CY2021Q3	us-gaap	Other Assets Current OtherAssetsCurrent	8068000	USD
CY2020Q3	us-gaap	Other Assets Current OtherAssetsCurrent	6489000	USD
CY2021Q3	us-gaap	Assets Current AssetsCurrent	183392000	USD
CY2020Q3	us-gaap	Assets Current AssetsCurrent	180179000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	122051000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	72743000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	8222000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	8222000	USD
CY2021Q3	us-gaap	Notes And Loans Receivable Gross Noncurrent NotesAndLoansReceivableGrossNoncurrent	30586000	USD
CY2020Q3	us-gaap	Notes And Loans Receivable Gross Noncurrent NotesAndLoansReceivableGrossNoncurrent	27609000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	159075000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	144663000	USD
CY2021Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	9244000	USD
CY2020Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	8565000	USD
CY2021Q3	us-gaap	Assets Assets	512570000	USD
CY2020Q3	us-gaap	Assets Assets	441981000	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	54397000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	51891000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	57648000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	40694000	USD
CY2021Q3	uti	Accrued Tool Sets AccruedToolSets	3292000	USD
CY2020Q3	uti	Accrued Tool Sets AccruedToolSets	3148000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14075000	USD
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23666000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	876000	USD
CY2020Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	129000	USD
CY2021Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2430000	USD
CY2020Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	2112000	USD
CY2021Q3	us-gaap	Liabilities Current LiabilitiesCurrent	132718000	USD
CY2020Q3	us-gaap	Liabilities Current LiabilitiesCurrent	121640000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	674000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	674000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	153228000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	134089000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29850000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	131000	USD
CY2021Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	7570000	USD
CY2020Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	8925000	USD
CY2021Q3	us-gaap	Liabilities Liabilities	324040000	USD
CY2020Q3	us-gaap	Liabilities Liabilities	265459000	USD
CY2021Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2020Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	100000000	shares
CY2021Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32915000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	32730000	shares
CY2021Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32833000	shares
CY2020Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	32647000	shares
CY2021Q3	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2020Q3	us-gaap	Common Stock Value CommonStockValue	3000	USD
CY2021Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000	shares
CY2020Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	700000	shares
CY2021Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	700000	shares
CY2020Q3	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100
CY2021Q3	us-gaap	Preferred Stock Liquidation Preference PreferredStockLiquidationPreference	100
CY2021Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2020Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2021Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	142314000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	141002000	USD
CY2021Q3	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	68853000	USD
CY2020Q3	us-gaap	Additional Paid In Capital Preferred Stock AdditionalPaidInCapitalPreferredStock	68853000	USD
CY2021Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	82000	shares
CY2020Q3	us-gaap	Treasury Stock Shares TreasuryStockShares	82000	shares
CY2021Q3	us-gaap	Treasury Stock Value TreasuryStockValue	365000	USD
CY2020Q3	us-gaap	Treasury Stock Value TreasuryStockValue	365000	USD
CY2021Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21996000	USD
CY2020Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-32971000	USD
CY2021Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-279000	USD
CY2020Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	188530000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	176522000	USD
CY2021Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	512570000	USD
CY2020Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	441981000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	335083000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300761000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	331504000	USD
CY2021	uti	Educational Services And Facilities EducationalServicesAndFacilities	166818000	USD
CY2020	uti	Educational Services And Facilities EducationalServicesAndFacilities	155932000	USD
CY2019	uti	Educational Services And Facilities EducationalServicesAndFacilities	178317000	USD
CY2021	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	153318000	USD
CY2020	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	148700000	USD
CY2019	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	160989000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	320136000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	304632000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	339306000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	14947000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-3871000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-7802000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	83000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	1152000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	1491000	USD
CY2021	us-gaap	Interest Expense InterestExpense	365000	USD
CY2020	us-gaap	Interest Expense InterestExpense	10000	USD
CY2019	us-gaap	Interest Expense InterestExpense	3220000	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	399000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	518000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	135000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1467000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	236000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1277000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	137000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	15183000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2594000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7665000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10602000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	203000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14581000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5264000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9331000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2744000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13118000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32766000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29812000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25438000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33123000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30113000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25438000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14581000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-279000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	USD
CY2019	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	0	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	14302000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	8008000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-7868000	USD
CY2018Q3	us-gaap	Stockholders Equity StockholdersEquity	126645000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2019	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	629000	USD
CY2019	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1390000	USD
CY2019	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5250000	USD
CY2019Q3	us-gaap	Stockholders Equity StockholdersEquity	114288000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2020	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	698000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2077000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	49153000	USD
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5264000	USD
CY2020Q3	us-gaap	Stockholders Equity StockholdersEquity	176522000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14581000	USD
CY2021	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	421000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1733000	USD
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5250000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-279000	USD
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	188530000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14581000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14027000	USD
CY2020	us-gaap	Depreciation And Amortization DepreciationAndAmortization	11804000	USD
CY2019	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13222000	USD
CY2019	us-gaap	Amortization Of Leased Asset AmortizationOfLeasedAsset	2682000	USD
CY2021	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	15605000	USD
CY2020	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	24273000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1718000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1767000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1166000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1733000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	2077000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	1390000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	345000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2020	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	0	USD
CY2019	us-gaap	Income Loss From Equity Method Investments IncomeLossFromEquityMethodInvestments	399000	USD
CY2021	uti	Training Equipment Credits Earned Used TrainingEquipmentCreditsEarnedUsed	364000	USD
CY2020	uti	Training Equipment Credits Earned Used TrainingEquipmentCreditsEarnedUsed	541000	USD
CY2019	uti	Training Equipment Credits Earned Used TrainingEquipmentCreditsEarnedUsed	302000	USD
CY2021	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	279000	USD
CY2020	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2019	us-gaap	Unrealized Gain Loss On Derivatives UnrealizedGainLossOnDerivatives	0	USD
CY2021	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	13000	USD
CY2020	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	52000	USD
CY2019	us-gaap	Gain Loss On Sale Of Other Assets GainLossOnSaleOfOtherAssets	-561000	USD
CY2021	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-8483000	USD
CY2020	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	13749000	USD
CY2019	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	1483000	USD
CY2021	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	1687000	USD
CY2020	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-2286000	USD
CY2019	us-gaap	Increase Decrease In Accounts And Notes Receivable IncreaseDecreaseInAccountsAndNotesReceivable	-1298000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4391000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	1016000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-3157000	USD
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	768000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	76000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-1016000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1790000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	7020000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	2942000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	16954000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2192000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	4650000	USD
CY2021	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	7145000	USD
CY2020	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	-6989000	USD
CY2019	us-gaap	Increase Decrease In Income Taxes Payable Net Of Income Taxes Receivable IncreaseDecreaseInIncomeTaxesPayableNetOfIncomeTaxesReceivable	166000	USD
CY2021	uti	Increase Decrease In Accrued Tool Sets And Other Current Liabilities IncreaseDecreaseInAccruedToolSetsAndOtherCurrentLiabilities	-2025000	USD
CY2020	uti	Increase Decrease In Accrued Tool Sets And Other Current Liabilities IncreaseDecreaseInAccruedToolSetsAndOtherCurrentLiabilities	-1863000	USD
CY2019	uti	Increase Decrease In Accrued Tool Sets And Other Current Liabilities IncreaseDecreaseInAccruedToolSetsAndOtherCurrentLiabilities	-300000	USD
CY2021	uti	Increase Decrease In Deferred Rent Liability IncreaseDecreaseInDeferredRentLiability	0	USD
CY2020	uti	Increase Decrease In Deferred Rent Liability IncreaseDecreaseInDeferredRentLiability	0	USD
CY2019	uti	Increase Decrease In Deferred Rent Liability IncreaseDecreaseInDeferredRentLiability	-1677000	USD
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-20469000	USD
CY2020	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-25617000	USD
CY2019	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	0	USD
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-1633000	USD
CY2020	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	739000	USD
CY2019	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	321000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	55185000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	11032000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	21746000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	61586000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	9262000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	6453000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	280000	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	64000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	34000	USD
CY2021	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2020	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	69678000	USD
CY2019	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	USD
CY2021	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	37651000	USD
CY2020	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	31289000	USD
CY2019	us-gaap	Proceeds From Sale And Maturity Of Held To Maturity Securities ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities	0	USD
CY2021	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	427000	USD
CY2020	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	1566000	USD
CY2019	us-gaap	Proceeds From Life Insurance Policies ProceedsFromLifeInsurancePolicies	0	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	277000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	261000	USD
CY2019	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	267000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-22951000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-45760000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-6152000	USD
CY2021	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	31150000	USD
CY2020	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2019	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	0	USD
CY2021	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	272000	USD
CY2020	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2019	us-gaap	Payments Of Financing Costs PaymentsOfFinancingCosts	0	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49153000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5250000	USD
CY2020	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5264000	USD
CY2019	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	5250000	USD
CY2021	uti	Principal Payments On Long Term Debt And Finance Lease Liability PrincipalPaymentsOnLongTermDebtAndFinanceLeaseLiability	383000	USD
CY2020	uti	Principal Payments On Long Term Debt And Finance Lease Liability PrincipalPaymentsOnLongTermDebtAndFinanceLeaseLiability	99000	USD
CY2019	uti	Principal Payments On Long Term Debt And Finance Lease Liability PrincipalPaymentsOnLongTermDebtAndFinanceLeaseLiability	1319000	USD
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	421000	USD
CY2020	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	698000	USD
CY2019	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	629000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	24824000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	43092000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-7198000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	57058000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8364000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	8396000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76803000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65442000	USD
CY2018Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	58104000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	12116000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	15113000	USD
CY2018Q3	us-gaap	Restricted Cash RestrictedCash	14055000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88919000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80555000	USD
CY2018Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	72159000	USD
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133721000	USD
CY2020Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	76803000	USD
CY2019Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	65442000	USD
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	12256000	USD
CY2020Q3	us-gaap	Restricted Cash RestrictedCash	12116000	USD
CY2019Q3	us-gaap	Restricted Cash RestrictedCash	15113000	USD
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	145977000	USD
CY2020Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	88919000	USD
CY2019Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	80555000	USD
CY2021	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	6712000	USD
CY2020	us-gaap	Proceeds From Income Tax Refunds ProceedsFromIncomeTaxRefunds	113000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	37000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	349000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	7000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	3220000	USD
CY2021	uti	Training Equipment Obtained In Exchange For Services TrainingEquipmentObtainedInExchangeForServices	679000	USD
CY2020	uti	Training Equipment Obtained In Exchange For Services TrainingEquipmentObtainedInExchangeForServices	985000	USD
CY2019	uti	Training Equipment Obtained In Exchange For Services TrainingEquipmentObtainedInExchangeForServices	772000	USD
CY2021	uti	Depreciation Of Training Equipment Obtained In Exchange For Services DepreciationOfTrainingEquipmentObtainedInExchangeForServices	1174000	USD
CY2020	uti	Depreciation Of Training Equipment Obtained In Exchange For Services DepreciationOfTrainingEquipmentObtainedInExchangeForServices	1345000	USD
CY2019	uti	Depreciation Of Training Equipment Obtained In Exchange For Services DepreciationOfTrainingEquipmentObtainedInExchangeForServices	1387000	USD
CY2021	uti	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	-1203000	USD
CY2020	uti	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	-490000	USD
CY2019	uti	Change In Accrued Capital Expenditures ChangeInAccruedCapitalExpenditures	316000	USD
CY2021	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	20039000	USD
CY2020	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	16565000	USD
CY2019	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	0	USD
CY2021	uti	Grants Awarded Amount Cares Act GrantsAwardedAmountCARESAct	19745000	USD
CY2020	uti	Grants Awarded Amount Cares Act GrantsAwardedAmountCARESAct	17184000	USD
CY2019	uti	Grants Awarded Amount Cares Act GrantsAwardedAmountCARESAct	0	USD
CY2021Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	2677000	USD
CY2020Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	13889000	USD
CY2019Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	0	USD
CY2021Q3	uti	Receivable Net Institutional Funds Cares Act ReceivableNetInstitutionalFundsCARESAct	0	USD
CY2020Q3	uti	Receivable Net Institutional Funds Cares Act ReceivableNetInstitutionalFundsCARESAct	1797000	USD
CY2019Q3	uti	Receivable Net Institutional Funds Cares Act ReceivableNetInstitutionalFundsCARESAct	0	USD
CY2021	us-gaap	Nature Of Operations NatureOfOperations	Business Description<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Founded in 1965, with more than 225,000 graduates in its history, Universal Technical Institute, Inc. (“we,” “us” or “our”) is a leading provider of transportation and technical training programs. As of September 30, 2021, we offered certificate, diploma or degree programs at 12 campuses across the United States under the banner of several well-known brands, including Universal Technical Institute (“UTI”), Motorcycle Mechanics Institute and Marine Mechanics Institute (collectively, “MMI”) and NASCAR Technical Institute (“NASCAR Tech”). Additionally, we offer manufacturer specific advanced training (“MSAT”) programs, including student-paid electives, at our campuses and manufacturer or dealer sponsored training at certain campuses and dedicated training centers. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We work closely with over 35 original equipment manufacturers and industry brand partners to understand their needs for qualified service professionals. Revenues generated from our schools consist primarily of tuition and fees paid by students. To pay for a substantial portion of their tuition, the majority of students rely on funds received from federal financial aid programs under Title IV Programs of the Higher Education Act of 1965, as amended (“HEA”), as well as from various veterans benefits programs. For further discussion, see Note 2 on “Summary of Significant Accounting Policies - Concentration of Risk” and Note 21 on “Government Regulation and Financial Aid.”</span></div>We offer the majority of our programs in a blended learning model that combines instructor-facilitated online teaching and demonstrations with hands-on labs. This blended learning format has allowed us to continue to offer our programs to our students during the COVID-19 pandemic and aligns with an increasing trend of online education now being offered as individuals seek life-long learning opportunities. On-campus labs are designed to meet or exceed the current national guidelines recommended by the Centers for Disease Control (“CDC”) as well as state and local mandates, while still meeting our accreditation and curriculum requirements.
CY2021Q3	uti	Number Of Graduated Technicians NumberOfGraduatedTechnicians	225000	technician
CY2021Q3	uti	Number Of Campuses NumberOfCampuses	12	campus
CY2021Q3	uti	Number Of Manufacturer Brand Partners And Employers NumberOfManufacturerBrandPartnersAndEmployers	35	plan
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with accounting principles generally accepted in the United States requires management to make certain estimates and assumptions. Such estimates and assumptions affect the reported amounts of assets, liabilities, revenues and expenses and related disclosures of contingent assets and liabilities. On an ongoing basis, we evaluate our estimates and assumptions, including those related to revenue recognition, our proprietary loan program, allowance for uncollectible accounts, investments, property and equipment, goodwill recoverability, self-insurance claim liabilities, income taxes, contingencies and stock-based compensation. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances. The results of our analysis form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions, and the impact of such differences may be material to our consolidated financial statements.</span></div>
CY2021	uti	Revenue Consisted Of Tuition RevenueConsistedOfTuition	0.99
CY2020	uti	Revenue Consisted Of Tuition RevenueConsistedOfTuition	0.99
CY2019	uti	Revenue Consisted Of Tuition RevenueConsistedOfTuition	0.99
CY2021	us-gaap	Debt Instrument Term DebtInstrumentTerm	P10Y
CY2021	us-gaap	Loan Processing Fee LoanProcessingFee	1100000	USD
CY2020	us-gaap	Loan Processing Fee LoanProcessingFee	900000	USD
CY2019	us-gaap	Loan Processing Fee LoanProcessingFee	1100000	USD
CY2021Q3	us-gaap	Goodwill Goodwill	8200000	USD
CY2019Q3	us-gaap	Goodwill Goodwill	8200000	USD
CY2020Q3	us-gaap	Goodwill Goodwill	8200000	USD
CY2021Q3	us-gaap	Accrued Insurance Current And Noncurrent AccruedInsuranceCurrentAndNoncurrent	2900000	USD
CY2021	us-gaap	Advertising Expense AdvertisingExpense	38700000	USD
CY2020	us-gaap	Advertising Expense AdvertisingExpense	39700000	USD
CY2019	us-gaap	Advertising Expense AdvertisingExpense	41200000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1800000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1400000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	500000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	400000	USD
CY2021	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Risk</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject us to concentrations of credit risk consist principally of cash and cash equivalents, restricted cash, short-term investments and receivables. As of September 30, 2021, we held cash and cash equivalents of $133.7 million and restricted cash of $12.3 million. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We place our cash and cash equivalents and restricted cash with high quality financial institutions and limit the amount of credit exposure with any one financial institution. We mitigate the concentration risk of our investments by limiting the amount invested in any one issuer. We mitigate the risk associated with our investment in corporate bonds by requiring a minimum credit rating of A. We have the ability and intention to hold these investments until maturity and therefore have classified these investments as held-to-maturity and recorded them at amortized cost.</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We extend credit for tuition and fees, for a limited period of time, to a majority of our students. A substantial portion is repaid through the student’s participation in federally funded financial aid programs. Transfers of funds from the financial aid programs to us are made in accordance with the ED requirements. Approximately 68% of our revenues, on a cash basis, were collected from funds distributed under Title IV Programs for the year ended September 30, 2021 as calculated under the 90/10 rule. Additionally, approximately 14% of our revenues, on a cash basis, were collected from funds distributed under various veterans benefits programs for the year ended September 30, 2021. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial aid and veterans benefits programs are subject to political and budgetary considerations. There is no assurance that such funding will be maintained at current levels. Extensive and complex regulations govern the financial assistance programs in which our students participate. Our administration of these programs is periodically reviewed by various regulatory agencies. Any regulatory violation could be the basis for the initiation of potential adverse actions, including a suspension, limitation, placement on reimbursement status or termination proceeding, which could have a material adverse effect on our business. ED and other regulators have increased the frequency and severity of their enforcement actions against postsecondary schools which have resulted in the imposition of material liabilities, sanctions, letter of credit requirements and other restrictions and, in some cases, resulted in the loss of schools’ eligibility to receive Title IV funds or in closure of the schools. </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If any of our institutions were to lose its eligibility to participate in federal student financial aid programs, the students at that institution would lose access to funds derived from those programs and would have to seek alternative sources of funds to pay their tuition and fees. Students obtain access to federal student financial aid through an ED prescribed application and eligibility certification process. Student financial aid funds are generally made available to students at prescribed intervals throughout their predetermined expected length of study. Students typically apply the funds received from the federal financial aid programs to pay their tuition and fees. The transfer of funds is from the financial aid program to the student, who then uses those funds to pay for a portion of the cost of their education. The receipt of financial aid funds reduces the student’s amounts due to us and has no impact on revenue recognition, as the transfer relates to the source of funding for the costs of education, which may occur either through Title IV or other funds and resources available to the student.</span></div>
CY2021Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	133700000	USD
CY2021Q3	us-gaap	Restricted Cash RestrictedCash	12300000	USD
CY2021	uti	Percentage Of Cash Basis Revenue Collected From Funds Distributed Under Title Iv Programs PercentageOfCashBasisRevenueCollectedFromFundsDistributedUnderTitleIvPrograms	0.68
CY2021	uti	Percentageof Cash Basis Revenue Collectedfrom Funds Distributed Under Veterans Benefits Programs PercentageofCashBasisRevenueCollectedfromFundsDistributedUnderVeteransBenefitsPrograms	0.14
CY2021Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	46489000	USD
CY2020Q3	us-gaap	Accounts And Notes Receivable Net AccountsAndNotesReceivableNet	53144000	USD
CY2021Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	57648000	USD
CY2020Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	40694000	USD
CY2021Q3	uti	Students Completing Catch Up Labs Percentage StudentsCompletingCatchUpLabsPercentage	0.01
CY2021Q3	uti	Tuition Receivables TuitionReceivables	16265000	USD
CY2020Q3	uti	Tuition Receivables TuitionReceivables	23565000	USD
CY2021Q3	uti	Income Taxes Receivable Cares Act IncomeTaxesReceivableCARESAct	0	USD
CY2020Q3	uti	Income Taxes Receivable Cares Act IncomeTaxesReceivableCARESAct	7145000	USD
CY2021Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	3673000	USD
CY2020Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	6494000	USD
CY2021Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	19938000	USD
CY2020Q3	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	37204000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2787000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	1793000	USD
CY2021Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	17151000	USD
CY2020Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	35411000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1793000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1097000	USD
CY2018Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	999000	USD
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1718000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1767000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1166000	USD
CY2021	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	724000	USD
CY2020	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1071000	USD
CY2019	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	1068000	USD
CY2021Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2787000	USD
CY2020Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1793000	USD
CY2019Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1097000	USD
CY2020Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	49500000	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	215000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset Before Accumulated Amortization FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization	359000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	309840000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	255106000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	187789000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	182363000	USD
CY2021Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	122051000	USD
CY2020Q3	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	72743000	USD
CY2021	uti	Lessee Operating Lease Number Of Contracts LesseeOperatingLeaseNumberOfContracts	9	campus
CY2021Q3	uti	Number Of Campuses NumberOfCampuses	12	campus
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	22623000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	29348000	USD
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	20469000	USD
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	159075000	USD
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	123000	USD
CY2020	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	102000	USD
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	6000	USD
CY2020	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	7000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	3682000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	4120000	USD
CY2021	us-gaap	Sublease Income SubleaseIncome	444000	USD
CY2020	us-gaap	Sublease Income SubleaseIncome	744000	USD
CY2021	us-gaap	Lease Cost LeaseCost	25990000	USD
CY2020	us-gaap	Lease Cost LeaseCost	32833000	USD
CY2020Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	144663000	USD
CY2021Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	94000	USD
CY2020Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	257000	USD
CY2021Q3	uti	Lease Right Of Use Asset LeaseRightOfUseAsset	159169000	USD
CY2020Q3	uti	Lease Right Of Use Asset LeaseRightOfUseAsset	144920000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14075000	USD
CY2021Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0308
CY2020Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0308
CY2020Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	23666000	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	73000	USD
CY2020Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	129000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	153228000	USD
CY2020Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	134089000	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	23000	USD
CY2020Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	131000	USD
CY2021Q3	uti	Lease Liability LeaseLiability	167399000	USD
CY2020Q3	uti	Lease Liability LeaseLiability	158015000	USD
CY2020Q3	uti	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	100000	USD
CY2021Q3	uti	Finance Lease Right Of Use Asset Accumulated Depreciation FinanceLeaseRightOfUseAssetAccumulatedDepreciation	100000	USD
CY2021Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M13D
CY2020Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y4M2D
CY2021Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P1Y3M25D
CY2020Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y18D
CY2021Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0431
CY2020Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0437
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	25617000	USD
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	119000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	0	USD
CY2021Q3	uti	Number Of Leased Properties NumberOfLeasedProperties	2	property
CY2020	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	99000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	30017000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	20321000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	0	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	215000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	19205000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	75000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	21380000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	23000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	21179000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	21480000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	21299000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due Year Five FinanceLeaseLiabilityPaymentsDueYearFive	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	100202000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due After Year Five FinanceLeaseLiabilityPaymentsDueAfterYearFive	0	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	204745000	USD
CY2021Q3	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	98000	USD
CY2021Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	37442000	USD
CY2021Q3	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	2000	USD
CY2021Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	167303000	USD
CY2021Q3	us-gaap	Finance Lease Liability FinanceLeaseLiability	96000	USD
CY2021Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	14075000	USD
CY2021Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	73000	USD
CY2021Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	153228000	USD
CY2021Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	23000	USD
CY2020	uti	Operating Leases Rent Expense Paid To Related Parties OperatingLeasesRentExpensePaidToRelatedParties	300000	USD
CY2019	uti	Operating Leases Rent Expense Paid To Related Parties OperatingLeasesRentExpensePaidToRelatedParties	2000000	USD
CY2021	uti	Lessee Operating Lease Minimum Annual Rent Increase LesseeOperatingLeaseMinimumAnnualRentIncrease	0.04
CY2012Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4000000	USD
CY2012Q3	us-gaap	Equity Method Investment Ownership Percentage EquityMethodInvestmentOwnershipPercentage	0.28
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4494000	USD
CY2019Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4338000	USD
CY2021	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	277000	USD
CY2020	us-gaap	Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital	261000	USD
CY2021Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4627000	USD
CY2020Q3	us-gaap	Equity Method Investments EquityMethodInvestments	4494000	USD
CY2020Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	12471000	USD
CY2020Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	51891000	USD
CY2021Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	13702000	USD
CY2021Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	29506000	USD
CY2020Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	28053000	USD
CY2021Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11189000	USD
CY2020Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	11367000	USD
CY2021Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	54397000	USD
CY2021Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0308
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	30982000	USD
CY2020Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	260000	USD
CY2021Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	256000	USD
CY2020Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	0	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	30726000	USD
CY2020Q3	us-gaap	Long Term Debt LongTermDebt	260000	USD
CY2021Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	876000	USD
CY2020Q3	us-gaap	Long Term Debt Current LongTermDebtCurrent	129000	USD
CY2021Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	29850000	USD
CY2020Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	131000	USD
CY2021Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.0308
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	876000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	855000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	861000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	892000	USD
CY2021Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	924000	USD
CY2021Q3	uti	Long Term Debt Maturity After Year Five LongTermDebtMaturityAfterYearFive	26574000	USD
CY2021Q3	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	30982000	USD
CY2021Q3	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	256000	USD
CY2021Q3	us-gaap	Long Term Debt LongTermDebt	30726000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-5000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-11250000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	-2000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	607000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	303000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	205000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	602000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	-10947000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	203000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	345000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	345000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10602000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	203000	USD
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2019	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2020	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.210
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	3188000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-545000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	-1610000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	134000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	480000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	246000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	165000	USD
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-3229000	USD
CY2020	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-6135000	USD
CY2019	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	1514000	USD
CY2021	uti	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	0	USD
CY2020	uti	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	-4270000	USD
CY2019	uti	Effective Income Tax Rate Reconciliation Net Operating Loss Carryback Amount EffectiveIncomeTaxRateReconciliationNetOperatingLossCarrybackAmount	0	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	163000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	102000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	602000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-10602000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	203000	USD
CY2021Q3	uti	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	43039000	USD
CY2020Q3	uti	Deferred Tax Assets Operating Lease Right Of Use Asset DeferredTaxAssetsOperatingLeaseRightOfUseAsset	40515000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	707000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	802000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	2277000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Compensation DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeCompensation	3940000	USD
CY2021Q3	uti	Deferred Tax Assets Tax Deferred Expense Accrued Tool Sets DeferredTaxAssetsTaxDeferredExpenseAccruedToolSets	865000	USD
CY2020Q3	uti	Deferred Tax Assets Tax Deferred Expense Accrued Tool Sets DeferredTaxAssetsTaxDeferredExpenseAccruedToolSets	831000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2815000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2665000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4595000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Deferred Income DeferredTaxAssetsDeferredIncome	4406000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5442000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6729000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	247000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	293000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	893000	USD
CY2021Q3	uti	Deferred Tax Liabilities Operating Lease Liability DeferredTaxLiabilitiesOperatingLeaseLiability	40984000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Charitable Contribution Carryforwards DeferredTaxAssetsCharitableContributionCarryforwards	1527000	USD
CY2021Q3	uti	Deferred Tax Assets Deductions Limited By Section382 DeferredTaxAssetsDeductionsLimitedBySection382	670000	USD
CY2020Q3	uti	Deferred Tax Assets Deductions Limited By Section382 DeferredTaxAssetsDeductionsLimitedBySection382	764000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	83000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	0	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13492000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17449000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	48141000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	45023000	USD
CY2020Q3	uti	Deferred Tax Liabilities Operating Lease Liability DeferredTaxLiabilitiesOperatingLeaseLiability	37083000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2056000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	2056000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	4587000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	5547000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1188000	USD
CY2021Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	48815000	USD
CY2020Q3	uti	Accrued Tool Sets AccruedToolSets	3100000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities Prepaid Expenses DeferredTaxLiabilitiesPrepaidExpenses	1011000	USD
CY2020Q3	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	45697000	USD
CY2021Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	674000	USD
CY2020Q3	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	674000	USD
CY2021Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13500000	USD
CY2020Q3	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	17400000	USD
CY2020	uti	Proceeds From Income Tax Refunds Cares Act ProceedsFromIncomeTaxRefundsCARESAct	11300000	USD
CY2020Q3	uti	Income Taxes Receivable Cares Act IncomeTaxesReceivableCARESAct	7100000	USD
CY2021Q3	uti	Net Prepaid Expenses From Excess Of Credits Earned Over Credits Used NetPrepaidExpensesFromExcessOfCreditsEarnedOverCreditsUsed	4800000	USD
CY2020Q3	uti	Net Prepaid Expenses From Excess Of Credits Earned Over Credits Used NetPrepaidExpensesFromExcessOfCreditsEarnedOverCreditsUsed	5500000	USD
CY2021Q3	uti	Accrued Tool Sets AccruedToolSets	3300000	USD
CY2021Q3	uti	Liability To Vendor For Vouchers Redeemed By Students LiabilityToVendorForVouchersRedeemedByStudents	1600000	USD
CY2020Q3	uti	Liability To Vendor For Vouchers Redeemed By Students LiabilityToVendorForVouchersRedeemedByStudents	1900000	USD
CY2021Q3	uti	Common Stock Shareholder Number Of Votes CommonStockShareholderNumberOfVotes	1	vote
CY2021	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5300000	USD
CY2020	us-gaap	Dividends Preferred Stock Cash DividendsPreferredStockCash	5300000	USD
CY2021Q3	uti	Preferred Stock Convertible Volume Weighted Average Price Rate PreferredStockConvertibleVolumeWeightedAveragePriceRate	2.5
CY2021	uti	Preferred Stock Convertible Consecutive Trading Days PreferredStockConvertibleConsecutiveTradingDays	20	day
CY2021	uti	Preferred Stock Convertible Conversion Cap PreferredStockConvertibleConversionCap	P120D
CY2021	uti	Preferred Stock Convertible Notice Of Conversion PreferredStockConvertibleNoticeOfConversion	P10D
CY2021Q3	uti	Preferred Stock Convertible Volume Weighted Average Price Rate PreferredStockConvertibleVolumeWeightedAveragePriceRate	2.5
CY2021	uti	Preferred Stock Convertible Notice Of Conversion PreferredStockConvertibleNoticeOfConversion	P10D
CY2020Q1	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	49200000	USD
CY2020Q4	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	35000000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	210000	shares
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1808000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2077000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1440000	USD
CY2021	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	452000	USD
CY2020	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	519000	USD
CY2019	us-gaap	Employee Service Share Based Compensation Tax Benefit From Compensation Expense EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense	360000	USD
CY2018Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	0	shares
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0
CY2018Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	210000	shares
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.14
CY2019Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	210000	shares
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.14
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y2M8D
CY2019Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	483000	USD
CY2020Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	210000	shares
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.14
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P5Y2M4D
CY2020Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	407000	USD
CY2021Q3	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Number Of Shares SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares	210000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.14
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M20D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	760000	USD
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	210000	shares
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	3.14
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P4Y2M4D
CY2021Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	760000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14581000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2021	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2020	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5264000	USD
CY2019	us-gaap	Preferred Stock Dividends Income Statement Impact PreferredStockDividendsIncomeStatementImpact	5250000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	9331000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2744000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13118000	USD
CY2021	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	3647000	USD
CY2020	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	1135000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	300761000	USD
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.52
CY2019	us-gaap	Undistributed Earnings Loss Allocated To Participating Securities Basic UndistributedEarningsLossAllocatedToParticipatingSecuritiesBasic	0	USD
CY2021	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	5684000	USD
CY2020	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	1609000	USD
CY2019	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	-13118000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32766000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29812000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25438000	shares
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.17
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.05
CY2021	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	5684000	USD
CY2020	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	1609000	USD
CY2019	uti	Net Income Loss Availableto Common Stockholders Basic Net NetIncomeLossAvailabletoCommonStockholdersBasicNet	-13118000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	32766000	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	29812000	shares
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	25438000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	357000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	301000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	0	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	33123000	shares
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	30113000	shares
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	25438000	shares
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.17
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.05
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.52
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21207000	shares
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21035000	shares
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21754000	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	54144000	shares
CY2020	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	51134000	shares
CY2019	us-gaap	Incremental Common Shares Attributable To Conversion Of Preferred Stock IncrementalCommonSharesAttributableToConversionOfPreferredStock	46971000	shares
CY2021	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1100000	USD
CY2020	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1000000	USD
CY2019	us-gaap	Defined Benefit Plan Contributions By Employer DefinedBenefitPlanContributionsByEmployer	1000000	USD
CY2021	uti	Deferred Compensation Arrangement Maximum Contribution Per Employee Percentage Of Regular Compensation DeferredCompensationArrangementMaximumContributionPerEmployeePercentageOfRegularCompensation	0.75
CY2021	uti	Deferred Compensation Arrangement Maximum Contribution Per Employee Percentage Of Incentive Compensation DeferredCompensationArrangementMaximumContributionPerEmployeePercentageOfIncentiveCompensation	1
CY2021Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	2800000	USD
CY2020Q3	us-gaap	Deferred Compensation Liability Classified Noncurrent DeferredCompensationLiabilityClassifiedNoncurrent	3000000	USD
CY2021Q3	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	3100000	USD
CY2020Q3	us-gaap	Cash Surrender Value Of Life Insurance CashSurrenderValueOfLifeInsurance	3300000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	335083000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	14947000	USD
CY2021	uti	Total Depreciationand Amortization TotalDepreciationandAmortization	14027000	USD
CY2021	us-gaap	Net Income Loss NetIncomeLoss	14581000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	-3871000	USD
CY2020	uti	Total Depreciationand Amortization TotalDepreciationandAmortization	11804000	USD
CY2020	us-gaap	Net Income Loss NetIncomeLoss	8008000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	331504000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	-7802000	USD
CY2019	uti	Total Depreciationand Amortization TotalDepreciationandAmortization	15904000	USD
CY2019	us-gaap	Net Income Loss NetIncomeLoss	-7868000	USD
CY2021Q3	us-gaap	Assets Assets	512570000	USD
CY2020Q3	us-gaap	Assets Assets	441981000	USD
CY2021	uti	Financing Obligation Deprecation And Amortization FinancingObligationDeprecationAndAmortization	1200000	USD
CY2020	uti	Financing Obligation Deprecation And Amortization FinancingObligationDeprecationAndAmortization	1300000	USD
CY2019	uti	Financing Obligation Deprecation And Amortization FinancingObligationDeprecationAndAmortization	1400000	USD
CY2021	uti	Percentageof Cash Basis Revenue Collectedfrom Funds Distributed Under Veterans Benefits Programs PercentageofCashBasisRevenueCollectedfromFundsDistributedUnderVeteransBenefitsPrograms	0.14
CY2020Q2	uti	Unusual Or Infrequent Items Or Both Amount Granted Cares Act UnusualOrInfrequentItemsOrBothAmountGrantedCARESAct	33000000	USD
CY2020Q2	uti	Proceeds Received Cares Act ProceedsReceivedCARESAct	16500000	USD
CY2020Q3	uti	Grants Awarded To Students Amount Cares Act GrantsAwardedToStudentsAmountCARESAct	16500000	USD
CY2020Q3	uti	Number Of Students Awarded Grants Cares Act NumberOfStudentsAwardedGrantsCARESAct	9000	student
CY2020Q2	uti	Amount Received To Offset Costs Cares Act AmountReceivedToOffsetCostsCARESAct	16500000	USD
CY2020Q2	uti	Number Of Campuses In Person Labs Resumed NumberOfCampusesInPersonLabsResumed	8	campus
CY2020Q2	uti	Number Of Campuses In Person Labs Resumed NumberOfCampusesInPersonLabsResumed	4	campus
	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	15100000	USD
CY2020	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	15100000	USD
CY2020	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	15100000	USD
CY2020	uti	Institutional Funds Additional Emergency Grants Cares Act InstitutionalFundsAdditionalEmergencyGrantsCARESAct	600000	USD
CY2020	uti	Total Institutional Funds Spent Cares Act TotalInstitutionalFundsSpentCARESAct	15700000	USD
CY2020Q3	uti	Institutional Funds Cares Act InstitutionalFundsCARESAct	13900000	USD
CY2020	uti	Total Institutional Funds Spent Cares Act TotalInstitutionalFundsSpentCARESAct	15700000	USD
CY2020Q3	us-gaap	Grants Receivable GrantsReceivable	2700000	USD
CY2021	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	900000	USD
CY2021	uti	Sanitization Supplies Partitions Labor Hours And Other Related Expenses SanitizationSuppliesPartitionsLaborHoursAndOtherRelatedExpenses	900000	USD
CY2021	uti	Unusual Or Infrequent Items Or Both Draws On Granted Funds Cares Act UnusualOrInfrequentItemsOrBothDrawsOnGrantedFundsCARESAct	2700000	USD
CY2021	uti	Unusual Or Infrequent Items Or Both Proceeds Received Crrsaa UnusualOrInfrequentItemsOrBothProceedsReceivedCRRSAA	16800000	USD
CY2021	uti	Unusual Or Infrequent Items Or Both Amount Of Student Grants Awarded Crrsaa UnusualOrInfrequentItemsOrBothAmountOfStudentGrantsAwardedCRRSAA	19700000	USD
CY2021Q3	uti	Unusual Or Infrequent Items Or Both Awards Granted UnusualOrInfrequentItemsOrBothAwardsGranted	10660	student
CY2021Q3	uti	Unusual Or Infrequent Items Or Both Grants Amount Included In Restricted Cash UnusualOrInfrequentItemsOrBothGrantsAmountIncludedInRestrictedCash	300000	USD

Files In Submission

Name	View Source	Status
0001261654-21-000073-index-headers.html	Edgar Link	pending
0001261654-21-000073-index.html	Edgar Link	pending
0001261654-21-000073.txt	Edgar Link	pending
0001261654-21-000073-xbrl.zip	Edgar Link	pending
exhibit211-9302021.htm	Edgar Link	pending
exhibit231-9302021.htm	Edgar Link	pending
exhibit311-9302021.htm	Edgar Link	pending
exhibit312-9302021.htm	Edgar Link	pending
exhibit321-9302021.htm	Edgar Link	pending
exhibit322-9302021.htm	Edgar Link	pending
exhibit46-9302021.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
uti-20210930.htm	Edgar Link	pending
uti-20210930.xsd	Edgar Link	pending
uti-20210930_cal.xml	Edgar Link	unprocessable
uti-20210930_def.xml	Edgar Link	unprocessable
uti-20210930_g1.jpg	Edgar Link	pending
uti-20210930_htm.xml	Edgar Link	completed
uti-20210930_lab.xml	Edgar Link	unprocessable
uti-20210930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$UTI
Universal Technical Institute Inc Stock $uti

2021 Q3 Form 10-K Financial Statement

#000126165421000073 Filed on December 02, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTI Universal Technical Institute Inc Stock $uti

2021 Q3 Form 10-K Financial Statement

#000126165421000073 Filed on December 02, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$UTI
Universal Technical Institute Inc Stock $uti